Clover Health (CLOV - Free Report) , a Medicare-backed insurance start-up, had a wild day of trading on Tuesday. CLOV skyrocketed over 100% at one point this morning, and closed up about 86% to $22.15 per share. According to FactSet data, more than 720 million shares changed hands by the closing bell.
A short squeeze looks to be in play for CLOV, just like we saw with other meme stocks AMC (AMC - Free Report) and GameStop (GME - Free Report) . The stock is one of the most shorted stocks across U.S. exchanges, and as of today, 43.5% of its float shares are sold short.
CLOV went public via venture capitalist Chamath Palihapitiya’s SPAC in October 2020, and is currently a Zacks Rank #4 (Sell).
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 77 billion devices by 2025, creating a $1.3 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 4 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2022.
Click here for the 4 trades >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Clover Health (CLOV - Free Report) , a Medicare-backed insurance start-up, had a wild day of trading on Tuesday. CLOV skyrocketed over 100% at one point this morning, and closed up about 86% to $22.15 per share. According to FactSet data, more than 720 million shares changed hands by the closing bell.
A short squeeze looks to be in play for CLOV, just like we saw with other meme stocks AMC (AMC - Free Report) and GameStop (GME - Free Report) . The stock is one of the most shorted stocks across U.S. exchanges, and as of today, 43.5% of its float shares are sold short.
CLOV went public via venture capitalist Chamath Palihapitiya’s SPAC in October 2020, and is currently a Zacks Rank #4 (Sell).
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 77 billion devices by 2025, creating a $1.3 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 4 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2022.
Click here for the 4 trades >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on GME - FREE
Get the latest research report on AMC - FREE
Get the latest research report on CLOV - FREE